Woodcock’s statement setting out the need for more money and powers comes a day after giving testimony to the Senate Committee on Health, Education, Labor, and Pensions. At that meeting, Woodcock described the work FDA did to ensure the supply of medical devices during the pandemic.
The volume of COVID-19 emergency use authorization requests for medical devices quickly rose to “two orders of magnitude” higher than the peak of any previous public health emergency, Woodcock said in the hearing testimony. To help manage the workload, FDA revised its EUA review processes to “incorporate the latest information on device availability and shortages.”….continue reading this article here
Article by: Nick Paul Taylor
Photo by: Win McNamee via Getty Images